VERACYTE, INC. - 8-K Filing

Veracyte acquired Convergent Genomics for $150M in cash plus up to $30M in milestone-based payments. (Items: 1.01 Entry into a Material Definitive Agreement, 2.01 Completion of Acquisition or Disposition of Assets, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $VCYT

Read the full article at SEC EDGAR

More Regulatory news